In vitro development of resistance to DX-619 and other quinolones in enterococci
Author(s) -
Paul A. Wickman,
Jennifer Ann Black,
Ellen Smith Moland,
K. S. Thomson,
Nancy D. Hanson
Publication year - 2006
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkl421
Subject(s) - gatifloxacin , moxifloxacin , quinolone , levofloxacin , ciprofloxacin , microbiology and biotechnology , enterococcus faecalis , ofloxacin , gemifloxacin , mutant , enterococcus faecium , minimum inhibitory concentration , biology , pharmacology , antibiotics , bacteria , staphylococcus aureus , biochemistry , genetics , gene
To investigate the molecular events involved in the development of quinolone resistance in enterococci.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom